-
Quantifying the Economic Burden of Undiagnosed Sleep Apnea in India’s Productive Population: A Health Economic Modeling Approach
Sep 9, 2025, 16:22 PM -
Evidence Strategy Starts Early: Integrating HTA Needs Through PICO Simulation in Metastatic Castration-Resistant Prostate Cancer
Sep 9, 2025, 16:22 PM -
A Comprehensive Approach Including Mailed FITs and Nurse Navigation for Colorectal Cancer Screening
Sep 9, 2025, 16:22 PM -
Delayed Access to Diabetes Technology in Children With Migration Background: A Cross-Sectional Study on Treatment Equity in Austria
Sep 9, 2025, 16:22 PM -
Positioning of the Eluvia™, Drug-Eluting Stent in the Treatment of Peripheral Artery Disease (PAD) in Türkiye: Insights From a Specialist Panel Survey and Focus Group Study
Sep 9, 2025, 16:22 PM -
Navigating Reimbursement Challenges for Pharmacological Interventions in Celiac Disease: Lessons From Analogous Conditions
Sep 9, 2025, 16:22 PM -
Trends in Hospital Treatment of Follicular Lymphoma in Germany
Sep 9, 2025, 16:22 PM -
Expert Consensus on a Definition for Children With Medical Complexity in England: A Modified Delphi Panel
Sep 9, 2025, 16:22 PM -
UDCA Treatment Response in Primary Biliary Cholangitis in the United States
Sep 9, 2025, 16:22 PM -
Understanding Reimbursement and Access Policies for Immunoglobulins and Other Plasma-Derived Medicinal Products Across Europe
Sep 9, 2025, 16:22 PM -
Microcosting Analysis of Oral, Subcutaneous, and Intravenous Second-line Multiple Sclerosis Treatments Administered at Home or in Hospital
Sep 9, 2025, 16:22 PM -
Comparison of Alignment Between EMA Indications and National Reimbursement Decisions in Italy for Orphan Drugs
Sep 9, 2025, 16:22 PM -
Advancing INN-Based Prescribing in Saudi Arabia’s Private Sector: Implications for Biologics and Biosimilars Utilization Under CHI Oversight
Sep 9, 2025, 16:22 PM -
Exploring Evidence Gaps in National Institute for Health and Care Excellence Early Value Assessments
Sep 9, 2025, 16:22 PM -
Clinical and Economic Outcomes of Cannabis-Based Formulations (CBD and CBD/CBG) for Autism Spectrum Disorder (ASD): A HEOR Model Study Analysis
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Perioperative Pembrolizumab for Early Stage Non-Small Cell Lung Cancer (NSCLC) in Greece
Sep 9, 2025, 16:22 PM -
Impact of Shared Treatment Decision Making Between Physicians and Patients on Treatment Satisfaction in Hypertension
Sep 9, 2025, 16:22 PM -
Public Health Impact of Herpes Zoster Vaccination in Immunocompromised Adults Aged 18-49 Years in the United Kingdom
Sep 9, 2025, 16:22 PM -
Using Propensity Weighting Methods With Real-World Data and Noncontrolled Extension Data From a Clinical Trial to Estimate Long-Term Treatment Effect: An Example in Alzheimer’s Disease
Sep 9, 2025, 16:22 PM -
Prediabetes Prevalence and Progression in the UAE: Insights for Early Intervention and Resource Optimization
Sep 9, 2025, 16:22 PM
